|
|
Volumn 42, Issue 2, 2006, Pages 259-260
|
|
Is "once-daily" regimen a key strategy for improving adherence to antiretroviral regimens? [3]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIRETROVIRUS AGENT;
EFAVIRENZ;
LAMIVUDINE PLUS ZIDOVUDINE;
NEVIRAPINE;
TENOFOVIR;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
AGE DISTRIBUTION;
DAILY LIFE ACTIVITY;
DRUG DOSE REGIMEN;
DRUG EFFICACY;
DRUG INFORMATION;
DRUG TOLERABILITY;
HAZARD ASSESSMENT;
HEALTH SURVEY;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LETTER;
MULTIVARIATE ANALYSIS;
PATIENT ASSESSMENT;
PATIENT COMPLIANCE;
PRIORITY JOURNAL;
QUESTIONNAIRE;
SAMPLE SIZE;
SIDE EFFECT;
WEIGHT CHANGE;
ADULT;
ANTI-HIV AGENTS;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HIV INFECTIONS;
HUMANS;
MALE;
PATIENT COMPLIANCE;
|
|
EID: 33745091134
PISSN: 15254135
EISSN: None
Source Type: Journal
DOI: 10.1097/01.qai.0000219781.58292.a6 Document Type: Letter |
|
Times cited : (9)
|
|
References (3)
|
